Akbar Ghorbani alvanegh

Dr. Akbar Ghorbani alvanegh

Baqiyatallah University of Medical Sciences, Tehran, Tehrān, Iran
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 June 2021 in Cancer Gene Therapy
Verified
Journal Article
Closed access
PDF file
RRRamazan Rezaei
Ramazan Rezaei
HGHADI ESMAEILI GOUVARCHIN GHALEH
HADI ESMAEILI GOUVARCHIN GHALEH
MFMahdieh Farzanehpour
Mahdieh Farzanehpour
RDRuhollah Dorostkar
Ruhollah Dorostkar
RRReza Ranjbar
Reza Ranjbar
Akbar Ghorbani alvaneghAkbar Ghorbani alvanegh
Akbar Ghorbani alvanegh

1 November 2020 in Multiple Sclerosis and Related Disorders
Verified
Journal Article
Closed access
MIMorteza Izadi
Morteza Izadi
STSafa Tahmasebi
Safa Tahmasebi
IPInna Pustokhina
Inna Pustokhina
AYAlexei Valerievich Yumashev
Alexei Valerievich Yumashev
TLTayyebeh Lakzaei
Tayyebeh Lakzaei
MAMajid Ahmadi
Majid Ahmadi

1 August 2021 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
Akbar Ghorbani alvaneghAkbar Ghorbani alvanegh
Akbar Ghorbani alvanegh
SGShahla Mohammad Ganji
Shahla Mohammad Ganji
AKAli Kamel
Ali Kamel
MTMahmood Tavallaie
Mahmood Tavallaie
ARAlireza Rafati
Alireza Rafati
HGHADI ESMAEILI GOUVARCHIN GHALEH
HADI ESMAEILI GOUVARCHIN GHALEH
Lung cancer is known as the second leading cause of cancer death. Finding ways to detect early-stage lung cancer can remarkably increase the survival rate. Biomarkers such as microRNAs can be helpful in cancer diagnosis, predicting its prognosis, and patients' chances of survival. Numerous studies have confirmed the correlation between microRNA expression and the likelihood of patients surviving after treatment. Consequently, it is necessary to study the expression profile of microRNAs during and after treatment. Oncolytic virotherapy and nanotherapy are two neoteric methods that use various vectors to deliver microRNAs into cancer cells. Although these treatments have not yet entered into the clinical trials, much progress has been made in this area. Analyzing the expression profile of microRNAs after applying nanotherapy and oncolytic virotherapy can evaluate the effectiveness of these methods. This review refers to the studies conducted about these two approaches. The advantages and disadvantages of these methods in delivery and affecting microRNA expression patterns are discussed below.

1 December 2015 in Interdisciplinary Toxicology
Verified
Journal Article
Open access
PDF file
MKMostafa Khafaei
Mostafa Khafaei
SSShahram Samie
Shahram Samie
SMSeyed Javad Mowla
Seyed Javad Mowla
Akbar Ghorbani alvaneghAkbar Ghorbani alvanegh
Akbar Ghorbani alvanegh
BMBehnaz Mirzaei
Behnaz Mirzaei
MNMohammadreza Nourani
Mohammadreza Nourani
Sulfur mustard (SM) or mustard gas is a chemical alkylating agent that causes blisters in the skin (blister gas), burns the eyes and causes lung injury. Some major cellular pathways are involved in the damage caused by mustard gas such as NF-κb signaling, TGF-β signaling, WNT pathway, inflammation, DNA repair and apoptosis. MicroRNAs are non-coding small RNAs (19-25 nucleotides) that are involved in the regulation of gene expression and are found in two forms, extracellular and intracellular. Changes in the levels of extracellular microRNAs are directly associated with many diseases, it is thus common to study the level of extracellular microRNAs as a biomarker to determine the pathophysiologic status. In this study, 32 mustard gas injured patients and 32healthy subjects participated. Comparative evaluation of miR-9 and miR-143 expression in urine samples was performed by Real Time PCR and Graph Pad software. The Mann Whitney t-test analysis of data showed that the expression level of miR-143 and miR-9 had a significant decrease in sulfur mustard individuals with the respective p-value of 0.0480 and 0.0272 compared to normal samples, with an imbalance of several above mentioned pathways. It seems that reducing the expression level of these genes has a very important role in the pathogenicity of mustard gas injured patients.

31 July 2023 in Infectious Agents and Cancer
Verified
Journal Article
Open access
PDF file
Akbar Ghorbani alvaneghAkbar Ghorbani alvanegh
Akbar Ghorbani alvanegh
MNMajid Mirzaei Nodooshan
Majid Mirzaei Nodooshan
RDRuhollah Dorostkar
Ruhollah Dorostkar
RRReza Ranjbar
Reza Ranjbar
BKBahman Jalali Kondori
Bahman Jalali Kondori
HGHADI ESMAEILI GOUVARCHIN GHALEH
HADI ESMAEILI GOUVARCHIN GHALEH
Background and aims: Colorectal Cancer (CRC) is a frequent malignancy with a high mortality rate. Specific inherited and environmental influences can affect CRC. Oncolytic viruses and bacteria in treating CRC are one of the innovative therapeutic options. This study aims to determine whether mesenchymal stem cells (MSCs) infected with the Newcastle Disease Virus (NDV) in combination with Lactobacillus casei extract (L. casei) have a synergistic effects on CRC cell line growth. Materials and methods: MSCs taken from the bone marrow of BALB/c mice and were infected with the 20 MOI of NDV. Then, using the CT26 cell line in various groups as a single and combined treatment, the anticancer potential of MSCs containing the NDV and L. casei extract was examined. The evaluations considered the CT26 survival and the rate at which LDH, ROS, and levels of caspases eight and nine were produced following various treatments. Results: NDV, MSCs-NDV, and L. casei in alone or combined treatment significantly increased apoptosis percent, LDH, and ROS production compared with the control group (P˂0.05). Also, NDV, in free or capsulated in MSCs, had anticancer effects, but in capsulated form, it had a delay compared with free NDV. The findings proved that L. casei primarily stimulates the extrinsic pathway, while NDV therapy promotes apoptosis through the activation of both intrinsic and extrinsic apoptosis pathways. Conclusions: The results suggest that MSCs carrying oncolytic NDV in combination with L. casei extract as a potentially effective strategy for cancer immunotherapy by promoting the generation of LDH, ROS, and apoptosis in the microenvironment of the CT26 cell line.

28 May 2018 in Journal of the Iranian Chemical Society
Verified
Journal Article
Closed access
PDF file
JNJamal Narimani
Jamal Narimani
JRJamal Rashidiani
Jamal Rashidiani
Akbar Ghorbani alvaneghAkbar Ghorbani alvanegh
Akbar Ghorbani alvanegh
HKHamid Kooshki
Hamid Kooshki